Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
CDNS Cadence tops Q4 2025 earnings estimates posts 141 percent year over year revenue growth as shares climb 236 percent What you need to know before buying Indonesia INDO Near Lows 20260511 FAST TRACK FTRK Stock Intrinsic Value Discussion FAST TRACK delays releasing financials amid review Aditxt ADTX Stock Stock Repair Trend Weakens 20260420 KNRX KNOREX posts 24 percent year over year Q1 2025 revenue gain shares fall 515 percent today SPIR Spire Global posts wider than expected Q4 2025 loss as shares tick higher on favorable investor sentiment Ross Stores Inc ROST Recent Price Outperformance and PreEarnings Fundamental Assessment New NFE Stock Valuation Gap Analysis Q4 2025 Profit Surprises What White WPAC disclosed about cash conversion VALE SA VALE at 1634 Buy Sell or Hold 20260518 Alg PU 2079 AQNB Stock Analysis RangeBound Near 2606 20260518 Matson MATX Falls 226 Watching 17109 Support 20260519 Oil Prices Rise as Trump Warns Iran European Markets Dip US President Trump Departs Beijing After Summit Focused on Trade Oil and Geopolitical Issues India No Longer Optional for Global Investors Say DWS and Nippon Life AMC Amid FII Outflows Bill Ackmans Pershing Square Builds Microsoft Stake Betting on AI and Cloud Growth Markets Turn Positive Ahead of NVIDIA Earnings Report NWS Q1 2026 Earnings EPS Beats Estimates as Digital Transformation Gains Traction Navient Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Higher MDLN Q1 2026 Earnings EPS Beats Estimates by 95 Stock Edges Higher Corsair Gaming Q1 2026 Earnings Strong EPS Beat Drives Stock Rally VLYPO Q1 2026 Earnings Slight EPS Beat Amid Stable Operations Murphy USA Inc MUSA Edges Lower as Consolidation Continues BK Technologies BKTI Edges Lower Amid Consolidation Key Levels in Focus RF Acquisition Corp III RFAM Edges Lower in Quiet Session Stays Within Support and Resistance Bands Sensei Biotherapeutics SNSE Slides 74 as Selling Pressure Builds Near Support Levels